Home Molecular Dx Molecular Biology

Molecular Biology

Latest
With NGS diagnostics
Molecular Biology

Illumina and Qiagen Enter 15-Year Diagnostics Partnership

Centogene’s CentoMD® rare disease variant database will be integrated into Qiagen’s bioinformatics suite in a rare disease bioinformatics collaboration by the companies. [Source: alengo/Getty]
Molecular Biology

NIH Commits $38M to Rare Disease Research and Affiliated Data Center

Exome sequencing designed to identify the gene responsible for chronic kidney disease has a direct impact on treatment for most patients
Molecular Biology

CareDx Gets Medicare Draft Coverage Decision for Heart Transplant Rejection Test

Medical: Sterile Urine sample and blood test
Molecular Biology

Urine Better than Blood for Determining Bladder Cancer Genomic Profile

Neuron system
Molecular Biology

MND Risk Split Equally Among Genetics, Environment

Molecular Biology

Portable Device Measures Efficacy of Targeted Cancer Drugs

Precision Medicine Group has formed Precision Value & Health
Molecular Biology

Multi-Gene Testing More Cost-Effective if Patients Receive Indicated Therapy

A liquid biopsy test has detected changes in the BRCA1 or BRCA2 genes associated with ovarian and breast cancer that signal when the disease stops responding to treatment through platinum chemotherapy or poly ADP-ribose polymerase (PARP) inhibitors. [Source: © freshidea/Fotolia]
Molecular Biology

Ovarian Cancer Blood Test May Eliminate Need for Diagnostic Exploratory Surgery

Molecular Biology

Thrive Launches with $110M and Johns Hopkins-developed Cancer Liquid Biopsy Tech

3d rendered ovarian cancer illustration.
Molecular Biology

Genetic Testing for Ovarian Cancer Patients is Underused

Load more

New Products

View More
Load more
Copyright © 2019 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up